News from reneuron group plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Oct 23, 2019, 18:35 ET ReNeuron Presents Positive Data at the 27th Annual Congress of the European Society of Gene and Cell Therapy on Lead Cell Line
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce that new data relating ...
Oct 14, 2019, 07:00 ET ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting
ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce that positive efficacy data...
Oct 02, 2019, 07:00 ET ReNeuron Announces Clinical Update and Conference Presentations
ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce new positive data in the...
Jul 16, 2019, 07:00 ET ReNeuron Expands Exosome IP Portfolio with Key Patent Grants
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announced that it has expanded its...
May 31, 2019, 07:00 ET ReNeuron to Participate in the Jefferies 2019 Global Healthcare Conference
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announced that ReNeuron's management...
May 08, 2019, 07:00 ET ReNeuron Provides Business Update and Results Notification
ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, announced a year-end business update ahead of its...
Apr 26, 2019, 07:00 ET ReNeuron Announces Presentation of Updated Efficacy and Safety Data from Retinitis Pigmentosa Study at the Sixth Annual Retinal Cell and Gene Therapy Innovation Summit
ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, announced updated positive preliminary results in the...
Apr 09, 2019, 07:00 ET ReNeuron Partners with Fosun Pharma in China
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce that it has signed an...
Apr 05, 2019, 07:00 ET ReNeuron to Present at the H.C. Wainwright Global Life Sciences Conference
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announced that Olav Hellebø, the...
Mar 18, 2019, 07:01 ET ReNeuron Announces Retinal Clinical Trial Progresses to Next Stage
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce a further update on...
Mar 18, 2019, 07:00 ET ReNeuron to Present at the Alliance for Regenerative Medicine's Cell & Gene Therapy Investor Day
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announced that Olav Hellebø, the...
Feb 20, 2019, 14:18 ET ReNeuron Group plc Announces Positive Preliminary Data in U.S. Retinitis Pigmentosa Trial
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announced positive preliminary results in the ...
